143 Stories, most recent news story added Wed Nov 18, 8:29 am ET
A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1 (avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies.
Sinovac Biotech Ltd. , a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
In case you didn't tune into The Washington Times' nationally syndicated radio show, "America's Morning News" - heard in Washington on WTNT-AM 570 and coast-to-coast via the Talk Radio Network - here's what four of Tuesday's guests told co-hosts Melanie Morgan and John McCaslin: - Former Attorney General Michael B. Mukasey: Mr. Mukasey, a retired chief federal judge in New York, blasted his ...
U.S. researchers linked several powerful computer systems to analyze enormous amounts of genetic data on the H5N1 virus, also known as avian flu.
AUSTIN, Texas----Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia .
Testimony of Alex Garza, MD, MPH, Assistant Secretary for Health Affairs and Chief Medical Officer, Office of Health Affairs, before the Senate Homeland Security and Governmental Affairs Committee on "H1N1 Flu: Getting the Vaccine to Where it is Most Needed"
Sinovac Biotech Ltd. , a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine.
Asia will receive a stockpile of 500,000 courses of H1N1 flu drugs by April next year to supplement any shortfall in the region, an official with a Japanese donor agency said on Tuesday.
DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009" to their offering.
Nov. 17 (Bloomberg) -- China and the World Health Organization agreed to open an influenza research center in Beijing to identify and share knowledge about new strains.
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say. The researchers linked many powerful computer systems together to analyze enormous amounts of genetic data collected from all publicly available isolated strains of the H5N1 ...
FDA backs off on Gulf Coast oyster safety plan In response to protests from the oyster industry and politicians, the Food and Drug Administration (FDA) recently announced the suspension, pending further study, of a plan to prevent the summertime contamination of Gulf Coast oysters by Vibrio vulnificus bacteria.
Flight Paths of Death
WEST HAVEN, Conn.----NanoViricides, Inc. , announced today that the Company’s President, Anil R. Diwan, PhD, has been invited to give a talk at the Nano and Green Tech 2009 Conference on November 18, 2009 .
SAN DIEGO----Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
LONDON----Immune Targeting Systems Ltd, whose synthetic universal influenza-A vaccine enters clinical trials in 2010, today announced that Ken Powell has joined the board as non-executive Chairman.
